Cellular reprogramming and epigenetic rejuvenation. (2021)
Attributed to:
Inhibition of reverse transcription in type I interferon mediated neuropathology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13148-021-01158-7
PubMed Identifier: 34488874
Publication URI: http://europepmc.org/abstract/MED/34488874
Type: Journal Article/Review
Volume: 13
Parent Publication: Clinical epigenetics
Issue: 1
ISSN: 1868-7075